Pharmacokinetic Parameter Estimation Using Simulated-Data Neural Networks
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional mathematical modeling methodologies for pharmacokinetics and pharmacodynamics are time and labor intensive, requiring significant computational resources and expert knowledge, limiting their adoption by non-experts, and existing methods for estimating pharmacokinetic parameters, such as the Trapezoidal Rule, are inaccurate due to reliance on assumptions and incomplete data.
Innovation Solution
Utilizing machine learning, specifically deep learning neural networks, to train on simulated and real-life pharmacokinetic data to predict parameters like AUC, Cmax, and t1/2, exploiting data patterns for improved accuracy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional mathematical modeling methodologies are used for PK/PD evaluation, then model evaluation and refinement can be performed, but the process becomes time and labor intensive requiring significant computational resources and expert knowledge
Solution Approach 1:
The system performs preliminary actions by generating simulated training data collections that include simulated time-series concentration datasets and corresponding simulated pharmacokinetic parameter values before actual PK/PD evaluation. This pre-computed training data enables the neural network to learn pharmacokinetic patterns in advance, allowing rapid prediction of pharmacokinetic parameters from real concentration data without requiring time-intensive conventional mathematical modeling during actual evaluation.
Solution Approach 2:
The system creates copies of real pharmacokinetic data by generating simulated training data collections that replicate the structure and characteristics of actual concentration-time profiles. These simulated datasets serve as training examples that teach the neural network to accurately predict pharmacokinetic parameters from real patient concentration data, replacing the need for repeated conventional mathematical modeling.
2Measurement precision
If conventional mathematical modeling methodologies are used for PK/PD evaluation, then model evaluation can be performed, but significant expert knowledge and computational resources are required
Solution Approach 1:
The system replaces the mechanical system of conventional mathematical modeling methodologies with a neural network-based computational system. Instead of using optimization-based algorithms like expectation-maximization or genetic algorithms that require expert knowledge and iterative manual adjustment, the neural network automatically learns pharmacokinetic patterns from simulated training data and directly predicts parameters from concentration data, significantly reducing system complexity and eliminating the need for expert intervention.
Solution Approach 2:
The neural network performs self-service by automatically learning pharmacokinetic patterns from the simulated training data collection and independently predicting pharmacokinetic parameters from real concentration data without requiring external expert knowledge or manual model refinement. The system self-trains on the training data and then autonomously evaluates new PK/PD cases.
3Reliability
If existing mathematical algorithms like expectation-maximization or genetic algorithms are used, then optimization-based PK modeling can be achieved, but many function and gradient evaluations involving significant trial-and-error are required
Solution Approach 1:
The system performs preliminary action by pre-computing extensive simulated training data collections that cover diverse pharmacokinetic scenarios before actual modeling. This pre-computed training data enables the neural network to learn robust pharmacokinetic patterns in advance, allowing rapid and reliable prediction of parameters from real concentration data without requiring repeated trial-and-error optimization during actual PK/PD evaluation.
Data Source
AI summary
A method and system for predicting at least one pharmacokinetic parameter of an agent administered to a subject. One or more processors train, by one or more processors, a neural network based on a simulated training data collection. The simulated training data collection comprising a simulated time-series concentration dataset and a simulated value for a pharmacokinetic parameter that corresponds to the simulated time-series concentration dataset. The one or more processors receive a time-series concentration dataset of the agent obtained from a subject. The one or more processors predict a value for the pharmacokinetic parameter using the time-series concentration dataset and the neural network that has been trained.